US 9981944
GDF-8 inhibitors
granted A61PA61P11/00A61P19/00
Quick answer
US patent 9981944 (GDF-8 inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P19/00, A61P19/10, A61P21/00